BIO: נכסי החברה Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories (BIO) profitability is based on the sale of high-cost reagents and digital PCR. The growth of total assets and liabilities on this chart confirms this trend, where the metric level stands at 10248.85. Conservative family management efficiently allocates resources, while steady demand from clinics and researchers guarantees business stability.

Bio-Rad Laboratories (BIO) dependence on government budgets and diagnostic demand makes the analysis of its resource base critical for assessing business resilience. Fluctuations in assets and resources, reverse-calculated via ROA as the sum of equity and debt, reveal hidden portfolio volatility, where any local decline necessitates a review of the liability structure to eliminate systemic risks when determining market value.